Global Health Diagnostic Evaluation
In partnership with Manuela de Allegri, Head of Health Economics and Finances at the Heidelberg Institute for Global Health, we are evaluating the economic value and financing of Global Health relevant diagnostic tests to inform policy and implementation. Initial projects are on rapid diagnostic tests in urine and stool to improve the point-of-care detection of tuberculosis in difficult to diagnose patients (children and people living with HIV). Additional projects assess the value of interventions targeting diagnosis in the private sector and for patients (e.g. through Direct Benefit Transfer) to increase notifications, treatment adherence and improve outcomes.